A team led by scientists at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and ...

CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in ...

Researchers from Mass General Brigham and the Broad Institute of MIT and Harvard have identified genetic modifications that ...

New research by the IU School of Medicine is looking at new ways to fight aggressive cancers. Right now the focus is on ...

Telomere damage drives T cell exhaustion. Antioxidants restored their cancer-fighting strength in mice. Tumor environments place heavy stress on immune cells that fight cancer. Limited oxygen, ...

Tumors are stressful places for cancer-fighting immune cells. Low oxygen, high acid levels, and other stressors put strain on mitochondria, the cell's energy factories, leading to T cell exhaustion ...

Researchers found that zeaxanthin, long associated with eye health, may also boost the body’s immune response against cancer.

Scientists are reprogramming how T cells work so they can fight against tumors, "turning them from cancer protectors into ...

Bispecific antibodies can be manufactured in bulk, stored, and delivered like traditional antibody drugs. This means they ...

Sickle cell disease (SCD) altered CD8+ T-cell chromatin architecture, triggering ferroptosis and weakening antitumor immunity. Hydrogen sulfide (H2S) treatment restored chromatin interactions and ...

Contrary to public concerns, receiving frequent COVID-19 booster vaccinations will not weaken the immune system, providing reassurance to vulnerable groups facing new variants. Study: No evidence of ...